A total of 451 strains of gram-positive bacteria were identified with a prototype of the Gram-Positive Identification card used in conjunction with the AutoMicrobic system (Vitek Systems, Inc., Hazelwood, Mo.). Of Interest in simple, rapid identification methods for these organisms as well as for the more firmly established gram-positive pathogens led us to investigate the identification of these bacteria with an automated computerized bacteriological system, the AutoMicrobic system (AMS) (Vitek Systems, Inc., Hazelwood, Mo. In most cases when the identification with the GPI card disagreed with the identification arrived at by the methods described above, the strains were retested with the card and subjected to the standard identification tests recommended by Vitek Systems, Inc. These recommended methods included Streptex latex agglutination testing for beta-hemolytic streptococci, the methods of Facklam (3) for nonhemolytic group D
Gram-positive bacteria account for a large portion of the organisms which are routinely isolated and identified in clinical laboratories. Many of these organisms (e.g., Staphylococcus aureus and groupable beta-hemolytic streptococci) can be identified or presumptively identified with simple and fairly rapid tests. However, identification at the species level of other grampositive organisms, such as coagulase-negative staphylococci and viridans streptococci, requires numerous time-consuming physiological tests. The scheme of Kloos and Schleifer (4) for the identification of human staphylococci uses 13 biochemical tests, and that of Facklam (2) for viridans streptococci requires the performance of 12 key tests.
Interest in simple, rapid identification methods for these organisms as well as for the more firmly established gram-positive pathogens led us to investigate the identification of these bacteria with an automated computerized bacteriological system, the AutoMicrobic system (AMS) (Vitek Systems, Inc., Hazelwood, Mo.). The general features of the AMS have been previously described by Aldridge et al. (1) . The GramPositive Identification (GPI) card, designed for use with the AMS, allows for the performance of miniaturized biochemical tests used in the identification of strains of streptococci, staphylococci, certain corynebacteria, Listeria monocytogenes, and Erysipelothrix rhusiopathiae. Our objective in this study was to evaluate the performance of a prototype of the card with strains of staphylococci, streptococci, and L. monocytogenes.
MATERIALS AND METHODS Bacterial strains. Most of the organisms examined in this study were isolated from clinical specimens in the bacteriology laboratory at the Massachusetts General Hospital, Boston. Stock strains of coagulase-negative staphylococci were supplied by W. E. Kloos, North Carolina State University, Raleigh. Strains of L. monocytogenes have been previously described (6) . Most of the streptococci were stored frozen in horse blood at -70°C, whereas most of the staphylococci and all of the L. monocytogenes strains were stored in a mixture of broth and horse blood on sterile glass beads at -70°C (8) . Strains of S. aureus, Streptococcus pneumoniae, and group A, B, C, and G streptococci were fresh clinical isolates that had not previously been frozen. For use in this study, the strains were propagated on horse blood agar (GIBCO Diagnostics, Madison, Wis.) or sheep blood agar plates (Remel Regional Media Laboratories, Inc., Lenexa, Kans.) incubated at 35°C in the presence of 3 to 5% CO2.
Identification methods. Staphylococci were subjected to a tube coagulase test with rabbit plasma (GIBCO Diagnostics). Coagulase-negative staphylococci were differentiated with the simplified scheme described by Kloos and Schleifer (4) . Streptococci were tested for the presence of Lancefield group antigens by the lysozyme-Streptomyces albus extraction method of Watson et al. (12) followed by microprecipitin testing or with Streptex latex agglutination testing (Wellcome Research Laboratories, Beckenham, England) . Group D streptococci were differentiated with tests described by Facklam (3) . Pneumococci were presumptively identified by colonial morphology, hemolytic reaction, and inhibition by optochin (Taxo P disks; BBL Microbiology Systems, Cockeysville, Md.). Viridans streptococci were identified with the modification of the scheme of Facklam (2) described by Ruoff and Kunz (9) .
In most cases when the identification with the GPI card disagreed with the identification arrived at by the methods described above, the strains were retested with the card and subjected to the standard identification tests recommended by Vitek Systems, Inc. These recommended methods included Streptex latex agglutination testing for beta-hemolytic streptococci, the methods of Facklam (3) for nonhemolytic group D Among the groupable beta-hemolytic streptococci, good agreement between serological and GPI card identifications was observed with group A and B streptococci. Some of the group B strain identifications were based on the hemolytic reaction of the isolate. The "S. agalactiael S. morbillorum" identification advised that if beta-hemolytic, the isolate resembled a group B streptococcus, but if nonhemolytic, it should be identified as the viridans species Streptococcus morbillorum. The GPI card identification of group C, F, and G streptococci agreed with serological identifications at levels of 30, 11, and 70%, respectively. The correctly identified group C and G streptococci were identified with a preliminary call ("S. equisimilislgroup G") with advice that the identification be confirmed serologically. The group F streptococci that were correctly identified by the card were called Streptococcus anginosus if beta-hemolytic or Streptococcus anginosus-constellatus if nonhemolytic. Table 1 shows that all nonhemolytic group D streptococcal species except Streptococcus bovis gave GPI card identifications that agreed with those obtained by conventional methods. S. pneumoniae strains were also identified with a high degree of accuracy by the GPI card.
Identifications of four of the nine viridans streptococcal species tested (Streptococcus uberis, Streptococcus sanguis II, Streptococcus mitis, and Streptococcus MG-intermedius) displayed only fair agreement (70% or higher) with identification by conventional methods (Table 1 ).
All strains of L. monocytogenes were correctly identified at high probabilities by the GPI card. Table 2 presents the nature of the discrepancies between identifications by conventional methods and identifications by the GPI card. With the exception of one staphylococcal strain identified as C. xerosis and one unidentified isolate, all of the misidentified staphylococci were identified as other species of the genus Staphylococcus. It should be noted that one strain of S. aureus was not identified by the card and that strains of questionable clinical importance (S. hominis, S. haemolyticus) were misidentified as S. saprophyticus, a species which is considered to be clinically significant (5) . Table 2 shows a number of instances in which the card misidentified groupable beta-hemolytic streptococci as viridans species. The inability of four of nine group F strains to grow in the wells of the card precluded their identification.
Misidentified strains of viridans streptococci were usually identified as other viridans species by the card. However, Table 2 shows misidentifications as S. pneumoniae for strains of S. sanguis II and one strain of S. anginosus-constellatus, and as groupable streptococci for strains of Streptococcus mutans and one strain of S. anginosus-constellatus.
DISCUSSION
Among the staphylococci tested with the GPI card, correct identifications were most prominent among the three clinically significant (5) species S. aureus, S. epidermidis, and S. saprophyticus. Of some concern is the misidentification of organisms of "probable" clinical significance, S. hominis and S. haemolyticus (5) , as the known pathogen S. saprophyticus. The examination of 37 strains of coagulase-negative staphylococcal species not identified by the card revealed that 21 of the strains were given definite species identifications instead of the "unidentified" or "Staphylococcus spp." designation. Incorporation into the card of additional substrates such as fructose, maltose, or mannose might be helpful in improving the accuracy of staphylococcal identification (4) . Although attempts have been made to simplify the identification of coagulase-negative staphylococci, it appears that there is some degree of physiological heterogeneity among these species and that a large battery of biochemical tests is needed to identify certain strains accurately (4) . Perhaps this situation is reflected by the seemingly decreased accuracy of the GPI card in the identification of these organisms.
The results obtained with group C, F, and G beta-hemolytic streptococci attest to the superiority of serological methods for the identification of these organisms. The apparent physiological unreactiveness of group F streptococci in the test wells of the card accounted for its failure to identify about half of the group F strains tested. VOL. 16, 1982 on October 18, 2017 by guest http://jcm.asm.org/ Insufficient growth (1) The taxonomical enigma reprsented by the viridans streptococci seemed to be an almost insurmountable challenge for the GPI card. The misidentification of one viridans species as another viridans species by the card is almost understandable in light of the confused taxonomic state of this group. It would appear that the appropriate substrates for identification of the viridans group have been included in the card; expansion of the data base may improve the identification of this group of organisms.
The time required for automated identification of the various gram-positive organisms tested ranged from 4 to 13 h. This clearly represents a reduction in the amount of time required to perform conventional identification tests for coagulase-negative staphylococci, viridans streptococci, L. monocytogenes, and species of group D streptococci. The advantage of the GPI card for identification of S. aureus or betahemolytic streptococci is questionable, since convenient rapid methods exist for serogrouping or identification of these organisms (7, 10, 11) .
In spite of the deficiencies of the prototype GPI card noted above, a high proportion of accurate identifications were noted among group A, B, and D streptococci, pneumococci, S. aureus, S. saprophyticus, and L. monocytogenes. Perhaps further testing and expansion of the data base of the system will improve the performance of the GPI card in other areas.
ADDENDUM IN PROOF
Vitek Systems, Inc., has recently informed us of changes in the GPI card which may affect its overall performance. Changes include alteration of substrate concentrations in four wells of the card, expansion of the data base, an increase in the minimum acceptable initial raw value reading for the positive control well, and a safeguard against processing results when readings have been interrupted by mechanical malfunctions. The critical value for an "unidentified" organism call was raised from a probability of 45 to 50%.
